Cover Image
市场调查报告书

处方药的全球市场:收益、市场趋势、成长率、市场占有率分析、预测

Prescription Pharmaceuticals Market - Global Revenue, Trends, Growth, Share, Size and Forecast

出版商 Scalar Market Research 商品编码 531373
出版日期 内容信息 英文 96 Pages
商品交期: 最快1-2个工作天内
价格
Back to Top
处方药的全球市场:收益、市场趋势、成长率、市场占有率分析、预测 Prescription Pharmaceuticals Market - Global Revenue, Trends, Growth, Share, Size and Forecast
出版日期: 2016年09月01日 内容信息: 英文 96 Pages
简介

本报告提供全球处方药的市场调查,市场定义和概要,市场的各种影响因素及市场机会分析,供应链、生态系统分析,法律制度,各疾病/治疗区分、剂型、地区/主要国家趋势与市场规模的变化与预测,竞争环境,企业简介等汇整数据。

第1章 市场概要

第2章 摘要整理

第3章 市场动态

  • 成长推动因素
  • 阻碍成长要素
  • 市场机会
  • 市场趋势

第4章 产业分析

  • 供应链分析
  • 法律规章分析
  • 宏观经济指标
  • 生态系统分析

第5章 市场分析、预测:各疾病、治疗种类

  • 简介
  • 心血管疾病
    • 全球市场的变化与预测
      • 各详细种类
      • 各地区
  • 癌症
    • 全球市场的变化与预测
      • 各详细种类
      • 各地区
  • 发炎性疾病
    • 全球市场的变化与预测
      • 各详细种类
      • 各地区
  • 感染疾病
    • 全球市场的变化与预测
      • 各详细种类
      • 各地区
  • 代谢性疾病
    • 全球市场的变化与预测
      • 各详细种类
      • 各地区
  • 呼吸系统疾病
    • 全球市场的变化与预测
      • 各详细种类
      • 各地区
  • 其他
    • 全球市场的变化与预测
      • 各详细种类
      • 各地区

第6章 市场分析、预测:各剂型

  • 简介
  • 胶囊
    • 全球市场的变化与预测
    • 市场规模成果:各地区
    • 市场规模的变化与预测:各地区
  • 平板计算机
    • 全球市场的变化与预测
    • 市场规模成果:各地区
    • 市场规模的变化与预测:各地区
  • 吸入剂、液剂
    • 全球市场的变化与预测
    • 市场规模成果:各地区
    • 市场规模的变化与预测:各地区
  • 非口服剂
    • 全球市场的变化与预测
    • 市场规模成果:各地区
    • 市场规模的变化与预测:各地区
  • 外用药
    • 全球市场的变化与预测
    • 市场规模成果:各地区
    • 市场规模的变化与预测:各地区

第7章 市场分析、预测:各地区

  • 简介
  • 北美
    • 市场规模的变化与预测:各国
    • 市场规模的变化与预测:各疾病、治疗种类
    • 市场规模的变化与预测:各剂型
  • 欧洲
    • 市场规模的变化与预测:各国
    • 市场规模的变化与预测:各疾病、治疗种类
    • 市场规模的变化与预测:各剂型
  • 亚洲
    • 市场规模的变化与预测:各国
    • 市场规模的变化与预测:各疾病、治疗种类
    • 市场规模的变化与预测:各剂型
  • 其他地区
    • 市场规模的变化与预测:各国
    • 市场规模的变化与预测:各疾病、治疗种类
    • 市场规模的变化与预测:各剂型

第8章 竞争环境

  • 市场占有率分析
  • 主要企业的地位

第9章 企业简介

  • AstraZeneca
  • Bayer AG
  • Gilead Sciences
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck & Co
  • Novartis A.G.
  • Pfizer
  • F. Hoffmann-La Roche
  • Sanofi S.A

第10章 SCALAR的全方位的市场检讨

第11章 附录

目录
Product Code: HC101

Title:
Prescription Pharmaceuticals Market
by Therapeutic Segments (Cardiovascular Disorders, Inflammatory Conditions, Metabolic Disorders, Oncology, Respiratory Disorders, Others), Formulations (Capsules, Inhalants, Parenterals, Tablets, Topicals) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2020.

Prescription Pharmaceuticals Market to grow from USD 761.85 billion in 2016 and reach USD 918.74 billion by 2020, growing at a CAGR of 4.8% during the forecast period.

Our industry experts anticipate that within the prescription pharmaceuticals market, the infectious disease will be the fastest-growing therapeutic segment, growing at a CAGR ranging from 5% to 10% by 2020. In addition, capsules will be the largest as well as the fastest-growing formulation segment, growing at a CAGR ranging from 5% to 10% by 2020. The Asia-Pacific region will be the fastest-growing geographic segment of the market, growing at a CAGR of more than 6% during the forecast period.

KEY BENEFITS OF THE REPORT:

  • Extensive evaluation of all the market dynamics that will impact this market during the forecast period
  • Granular understanding of the historical market trend and the resultant market forecast
  • Deeper understanding of the behavior of the key players and innovators influencing this market

KEY PREMIUM INDUSTRY INSIGHTS:

  • The increase in the aging population and lengthening life expectancies, the rising affluence in the emerging markets and the widespread prevalence of the chronic diseases are the major drivers of the prescription pharmaceuticals market.
  • The evolution of the population structure will increase the pressure on the long-term publicly-funded health support programs for the elderly, driving the demand for the prescription pharmaceuticals market.
  • There will be a paradigm shift from the acute to chronic illnesses, thereby leading to an increased use of the prescription pharmaceuticals. Chronic diseases, namely, heart diseases, strokes, cancer, type 2 diabetes, obesity, and arthritis pose a serious threat to the health of the world population.
  • The factors such as the rising average age of the population and the changing epidemiologic profile of the global population are the major contributors to the high prevalence of the chronic diseases.
  • The management of chronic diseases is costly, primarily due to the high cost of the prescription pharmaceuticals. For instance, the cost of the management of diabetes is projected to increase to USD 745 billion by 2030.
  • The rise in the generic and biosimilar products and the changing government policies will act as the major restraints for the growth of this market.

MARKET SEGMENTATION:

This report analyzes the prescription pharmaceuticals market by the following segments:

Prescription Pharmaceuticals Market, by Therapeutic Segments

  • Cardiovascular Disorders
  • Oncology
  • Inflammatory Conditions
  • Infectious Diseases
  • Metabolic Disorders
  • Respiratory Disorders
  • Other Therapeutic Segments

Prescription Pharmaceuticals Market, by Formulations

  • Capsules
  • Tablets
  • Inhalants and Liquids
  • Parenterals
  • Topicals

KEY MARKET PLAYERS:

Key players in the prescription pharmaceuticals market include:

  • AG, Gilead Sciences, Inc.
  • AstraZeneca plc
  • GlaxoSmithKline plc,
  • Johnson & Johnson,
  • Merck & Co, A.G.,
  • Pfizer, Inc.
  • F. Hoffmann-La Roche

Table of Contents

1.MARKET OVERVIEW

  • 1.1.Definitions
  • 1.2.Research Methodology
    • 1.2.1.Primary Data
    • 1.2.2.Secondary Data
    • 1.2.3.Machine Learning
    • 1.2.4.Research Scope
    • 1.2.5.Years Considered
    • 1.2.6.Currency & Pricing
  • 1.3.Market Segmentation

2.EXECUTIVE SUMMARY

  • 2.1.Global Prescription Pharmaceuticals Market
  • 2.2.Global Prescription Pharmaceuticals Market Size (US$ Billion), By Therapeutic Segments (2015 vs. 2020)
  • 2.3.Global Prescription Pharmaceuticals Market Size (US$ Billion), By Formulations (2015 vs. 2020)
  • 2.4.Global Prescription Pharmaceuticals Market Size (US$ Billion), By Regions (2015 vs. 2020)

3.MARKET DYNAMICS

  • 3.1.Drivers
    • 3.1.1.Increase in the Ageing Population and Lengthening Life Expectancies
    • 3.1.2.Rising Affluence in Emerging Markets
    • 3.1.3.Widespread Prevalence of Chronic Diseases
  • 3.2.Restraints
    • 3.2.1.Government Policies Aimed at Lowering Prescription Drug Prices
    • 3.2.2.Generics and Biosimilars Drugs Hampering Prescription Pharmaceuticals Growth
  • 3.3.Opportunities
    • 3.3.1.Emerging Marketsare key Pockets
    • 3.3.2.Increased Healthcare Awareness
  • 3.4.Trends
    • 3.4.1.Increased Spending on Specialty Medicines - Hepatitis, Autoimmune Diseases, and Oncology

4.INDUSTRY ANALYSIS

  • 4.1.Supply Chain Analysis
  • 4.2.Regulatory Analysis
  • 4.3.Macroeconomic Indicators
    • 4.3.1.Healthcare Spending (US$ Billion), by Regions (2005 to 2014)
    • 4.3.2.Per Capita Healthcare Spending (US$), by Regions (2005 to 2014)
    • 4.3.3.Public Healthcare Spending (US$ Billion), by Regions (2005 to 2014)
  • 4.4.Ecosystem Analysis
    • 4.4.1.Market Size of Top-25 Prescription Pharmaceuticals (2013 to 2015)
    • 4.4.2.Therapeutic Segments Benchmarking

5.PRESCRIPTION PHARMACEUTICALS MARKET, BY THERAPEUTIC SEGMENTS

  • 5.1.Introduction
    • 5.1.1.Global Prescription Pharmaceuticals Market Size& Forecast (US$ billion), By Therapeutic Segments (2015)
    • 5.1.2.Global Prescription Pharmaceuticals Market Size& Forecast (US$ billion), By Therapeutic Segments (2013 - 2020)
  • 5.2.Cardiovascular Disorders
    • 5.2.1.Global Prescription Pharmaceuticals Market Size& Forecast (US$ billion), By Cardiovascular Disorders, (2013 - 2020)
    • 5.2.2.Global Prescription Pharmaceuticals for Cardiovascular Disorders Market Size & Forecast (US$ billion), By Regions (2015 vs. 2020)
    • 5.2.3.Global Prescription Pharmaceuticals for Cardiovascular Disorders Market Size& Forecast (US$ billion), By Regions (2013 - 2020)
    • 5.2.4.North America Prescription Pharmaceuticals for Cardiovascular Disorders Market Size & Forecast (US$ billion), By Country (2013 - 2020)
    • 5.2.5.Europe Prescription Pharmaceuticals for Cardiovascular Disorders Market Size& Forecast (US$ billion), By Country (2013 - 2020)
    • 5.2.6.Asia Prescription Pharmaceuticals for Cardiovascular Disorders Market Size (US$ Billion)& Forecast (US$ billion), By Country (2013 - 2020)
    • 5.2.7.Rest of the World (RoW) Prescription Pharmaceuticals for Cardiovascular Disorders Market Size & Forecast (US$ billion), By Country (2013 - 2020)
  • 5.3.Oncology
    • 5.3.1.Global Prescription Pharmaceuticals Market Size& Forecast (US$ billion), By Oncology (2013 - 2020)
    • 5.3.2.Global Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ billion), By Regions (2015 vs. 2020)
    • 5.3.3.Global Prescription Pharmaceuticals for Oncology Market Size& Forecast (US$ billion), By Regions (2013 - 2020)
    • 5.3.4.North America Prescription Pharmaceuticals for Oncology Market Size& Forecast (US$ billion), By Country (2013 - 2020)
    • 5.3.5.Europe Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ billion), By Country (2013 - 2020)
    • 5.3.6.Asia Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ billion), By Country (2013 - 2020)
    • 5.3.7.Rest of the World (RoW) Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ billion), By Country (2013 - 2020)
  • 5.4.Inflammatory Conditions
    • 5.4.1.Global Prescription Pharmaceuticals Market Size& Forecast (US$ billion),By Inflammatory Conditions (2013 - 2020)
    • 5.4.2.Global Prescription Pharmaceuticals Market Size& Forecast for Inflammatory Conditions (US$ billion), By Regions (2015 vs. 2020)
    • 5.4.3.Global Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ billion), By Regions (2013 - 2020)
    • 5.4.4.North America Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ billion), By Country (2013 - 2020)
    • 5.4.5.Europe Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ billion), By Country (2013 - 2020)
    • 5.4.6.Asia Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ billion), By Country (2013 - 2020)
    • 5.4.7.Rest of the World (RoW) Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ billion), By Country (2013 - 2020)
  • 5.5.Infectious Diseases
    • 5.5.1.Global Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Infectious Diseases (2013 - 2020)
    • 5.5.2.Global Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ billion), By Regions (2015 vs. 2020)
    • 5.5.3.Global Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ billion), By Regions (2013 - 2020)
    • 5.5.4.North America Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ billion), By Country (2013 - 2020)
    • 5.5.5.Europe Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ billion), By Country (2013 - 2020)
    • 5.5.6.Asia Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ billion), By Country (2013 - 2020)
    • 5.5.7.Rest of the World (RoW) Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ billion), By Country (2013 - 2020)
  • 5.6.Metabolic Disorders
    • 5.6.1.Global Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Metabolic Disorders (2013 - 2020)
    • 5.6.2.Global Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ billion), By Regions (2015 vs. 2020)
    • 5.6.3.Global Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ billion), By Regions (2013 - 2020)
    • 5.6.4.North America Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ billion), By Country (2013 - 2020)
    • 5.6.5.Europe Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ billion), By Country (2013 - 2020)
    • 5.6.6.Asia Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ billion), By Country (2013 - 2020)
    • 5.6.7.Rest of the World (RoW) Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ billion), By Country (2013 - 2020)
  • 5.7.Respiratory Disorders
    • 5.7.1.Global Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Respiratory Disorders (2013 - 2020)
    • 5.7.2.Global Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ billion), By Regions (2015 vs. 2020)
    • 5.7.3.Global Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ billion), By Regions (2013 - 2020)
    • 5.7.4.North America Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ billion), By Country (2013 - 2020)
    • 5.7.5.Europe Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ billion), By Country (2013 - 2020)
    • 5.7.6.Asia Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ billion), By Country (2013 - 2020)
    • 5.7.7.Rest of the World (RoW) Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ billion), By Country (2013 - 2020)
  • 5.8.Other Therapeutic Segments
    • 5.8.1.Global Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Other Therapeutic Segments (2013 - 2020)
    • 5.8.2.Global Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ billion), By Regions (2015 vs. 2020)
    • 5.8.3.Global Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ billion), By Regions (2013 - 2020)
    • 5.8.4.North America Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ billion), By Country (2013 - 2020)
    • 5.8.5.Europe Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ billion), By Country (2013 - 2020)
    • 5.8.6.Asia Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ billion), By Country (2013 - 2020)
    • 5.8.7.Rest of the World (RoW) Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ billion), By Country (2013 - 2020)

6.PRESCRIPTION PHARMACEUTICALS MARKET, BY FORMULATIONS

  • 6.1.Introduction
    • 6.1.1.Global Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Formulations (2015)
    • 6.1.2.Global Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Formulations (2013 - 2020)
  • 6.2.Capsules
    • 6.2.1.Global Capsules Market Size & Forecast (US$ billion) (2013 - 2020)
    • 6.2.2.Global Capsules Market Size & Forecast (US$ billion), By Regions (2015 vs. 2020)
    • 6.2.3.Global Capsules Market Size & Forecast (US$ billion), By Regions (2013 - 2020)
  • 6.3.Tablets
    • 6.3.1.Global Tablets Market Size & Forecast (US$ billion), (2013 - 2020)
    • 6.3.2.Global Tablets Market Size & Forecast (US$ billion), By Regions (2015 vs. 2020)
    • 6.3.3.Global Tablets Market Size & Forecast (US$ billion), By Regions (2013 - 2020)
  • 6.4.Inhalants and Liquids
    • 6.4.1.Global Inhalants and Liquids Market Size & Forecast (US$ billion), (2013 - 2020)
    • 6.4.2.Global Inhalants and Liquids Market Size & Forecast (US$ billion), By Regions (2015 vs. 2020)
    • 6.4.3.Global Inhalants and Liquids Market Size & Forecast (US$ billion), By Regions (2013 - 2020)
  • 6.5.Parenterals
    • 6.5.1.Global Parenteral Market Size Market Size & Forecast (US$ billion), (2013 - 2020)
    • 6.5.2.Global Parenteral Market Size & Forecast (US$ billion), By Regions (2015 vs. 2020)
    • 6.5.3.Global Parenterals Market Size & Forecast (US$ billion), By Regions (2013 - 2020)
  • 6.6.Topicals
    • 6.6.1.Global TopicalsMarket Size & Forecast (US$ billion), (2013 - 2020)
    • 6.6.2.Global Topicals Market Size & Forecast (US$ billion), By Regions (2015 vs. 2020)
    • 6.6.3.Global Topicals Market Size & Forecast (US$ billion), By Regions (2013 - 2020)

7.PRESCRIPTION PHARMACEUTICALS MARKET, BY REGIONS

  • 7.1.Introduction
    • 7.1.1.Global Prescription Pharmaceuticals Market Size vs. CAGR% (2015 - 2020), By Regions
    • 7.1.2.Global Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Regions (2013 - 2020)
  • 7.2.North America
    • 7.2.1.North America Prescription Pharmaceuticals Market Size & Forecast (US$ billion),By Country (2013 - 2020)
    • 7.2.2.North America Prescription Pharmaceuticals Market Size & Forecast (US$ billion), (2013 - 2020)
    • 7.2.3.North America Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Therapeutic Segments (2013 - 2020)
    • 7.2.4.North America Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Formulations (2013 - 2020)
  • 7.3.Europe
    • 7.3.1.Europe Prescription Pharmaceuticals Market Size & Forecast (US$ billion),By Country (2013 - 2020)
    • 7.3.2.Europe Prescription Pharmaceuticals Market Size & Forecast (US$ billion), (2013 - 2020)
    • 7.3.3.Europe Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Therapeutic Segments (2013 - 2020)
    • 7.3.4.Europe Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Formulations (2013 - 2020)
  • 7.4.Asia
    • 7.4.1.Asia Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Country (2013 - 2020)
  • 7.5.Asia Prescription Pharmaceuticals Market Size & Forecast (US$ billion), (2013 - 2020)
    • 7.5.1.Asia Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Therapeutic Segments (2013 - 2020)
    • 7.5.2.Asia Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Formulations (2013 - 2020)
  • 7.6.Rest of the World (RoW)
    • 7.6.1.RoW Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Country, (2013 - 2020)
    • 7.6.2.Row Prescription Pharmaceuticals Market Size & Forecast (US$ billion), (2013 - 2020)
    • 7.6.3.RoW Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Therapeutic Segments (2013 - 2020)
    • 7.6.4.RoW Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Formulations (2013 - 2020)

8.COMPETITIVE LANDSCAPE

  • 8.1.Market Share Analysis
  • 8.2.Market Positioning of Key Players

9.COMPANY PROFILES

  • 9.1.AstraZeneca (U.K.)
    • 9.1.1.Financial Overview: AstraZeneca plc (U.K.) (Europe) (2013 to 2015)
    • 9.1.2.Revenues of Top-3 Pharmaceutical Products AstraZeneca plc (U.K.) (Europe) (2013 to 2015)
  • 9.2.Bayer AG (Germany)
    • 9.2.1.Financial Overview: Bayer AG (Germany)(Europe) (2013 to 2015)
    • 9.2.2.Revenues of Top-3 Pharmaceutical Products:Bayer AG (Germany)(Europe) (2013 to 2015)
  • 9.3.Gilead Sciences
    • 9.3.1.Financial Overview: Gilead Sciences, Inc. (U.S.)(2013 to 2015)
    • 9.3.2.Revenues of Top-3 Pharmaceutical Products:Gilead Sciences, Inc. (U.S.) (2013 to 2015)
  • 9.4.GlaxoSmithKline
    • 9.4.1.Financial Overview: GlaxoSmithKline plc (U.K.) (Europe)(2013 to 2015)
    • 9.4.2.Revenues of Top-3 Pharmaceutical Products:GlaxoSmithKline plc (U.K.) (Europe) (2013 to 2015)
  • 9.5.Johnson & Johnson
    • 9.5.1.Financial Overview: Johnson & Johnson (U.S.) (2013 to 2015)
    • 9.5.2.Revenues of Top-3 Pharmaceutical Products: Johnson & Johnson (U.S.) (2013 to 2015)
  • 9.6.Merck & Co
    • 9.6.1.Financial Overview: Merck & Co., Inc. (U.S.) (2013 to 2015)
    • 9.6.2.Revenues of Top-3 Pharmaceutical Products: Merck & Co., Inc. (U.S.) (2013 to 2015)
  • 9.7.Novartis A.G.
    • 9.7.1.Financial Overview: Novartis AG (Switzerland) (Europe) (2013 to 2015)
    • 9.7.2.Revenues of Top-3 Pharmaceutical Products: Novartis AG (Switzerland) (Europe) (2013 to 2015)
  • 9.8.Pfizer
    • 9.8.1.Financial Overview: Pfizer Inc. (U.S.) (2013 to 2015)
    • 9.8.2.Revenues of Top-3 Pharmaceutical Products: Pfizer Inc. (U.S.) (2013 to 2015)
  • 9.9.F. Hoffmann-La Roche
    • 9.9.1.Financial Overview: F. Hoffmann-La Roche (Switzerland) (Europe) (2013 to 2015)
    • 9.9.2.Revenues of Top-3 Pharmaceutical Products: Hoffmann-La Roche (Switzerland) (Europe) (2013 to 2015)
  • 9.10.Sanofi S.A
    • 9.10.1.Financial Overview: Sanofi S.A. (France) (Europe) (2013 to 2015)
    • 9.10.2.Revenues of Top-3 Pharmaceutical Products: Sanofi S.A. (France) (Europe) (2013 to 2015)

10.SCALAR 360 DEGREE MARKET REVIEW

11.APPENDIX

  • 11.1.Acronyms
  • 11.2.Related Reports

List of Tables

  • Table 1. Global Prescription Pharmaceuticals Market
  • Table 2. Global Prescription Pharmaceuticals Market Size (US$ Billion), By Therapeutic Segments (2015 vs. 2020)
  • Table 3. Global Prescription Pharmaceuticals Market Size (US$ Billion), By Formulations (2015 vs. 2020)
  • Table 4. Global Prescription Pharmaceuticals Market Size (US$ Billion), By Regions (2015 vs. 2020)
  • Table 5. Healthcare Spending (US$ Billion), by Regions (2005 to 2014)
  • Table 6. Per Capita Healthcare Spending (US$), by Regions (2005 to 2014)
  • Table 7. Public Healthcare Spending (US$ Billion), by Regions (2005 to 2014)
  • Table 8. Market Size of Top-25 Prescription Pharmaceuticals (2013 to 2015)
  • Table 9. Therapeutic Segments Benchmarking
  • Table 10. Global Prescription Pharmaceuticals Market Size& Forecast (US$ billion),By Therapeutic Segments (2013 - 2020)
  • Table 11. Global Prescription Pharmaceuticals Market Size& Forecast (US$ billion), By Cardiovascular Disorders, (2013 - 2020)
  • Table 12. Global Prescription Pharmaceuticals for Cardiovascular Disorders Market Size& Forecast (US$ billion), By Regions (2013 - 2020)
  • Table 13. North America Prescription Pharmaceuticals for Cardiovascular Disorders Market Size & Forecast (US$ billion), By Country (2013 - 2020)
  • Table 14. Europe Prescription Pharmaceuticals for Cardiovascular Disorders Market Size & Forecast (US$ billion), By Country (2013 - 2020)
  • Table 15. Asia Prescription Pharmaceuticals for Cardiovascular Disorders Market Size (US$ Billion) for Asia, By Country (2013 - 2020)
  • Table 16. Rest of the World (RoW) Prescription Pharmaceuticals for Cardiovascular Disorders Market Size & Forecast (US$ billion), By Country (2013 - 2020)
  • Table 17. Global Prescription Pharmaceuticals Market Size & Forecast (US$ billion),By Oncology (2013 - 2020)
  • Table 18. Global Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ billion), By Regions (2013 - 2020)
  • Table 19. North America Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ billion), By Country (2013 - 2020)
  • Table 20. Europe Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ billion), By Country (2013 - 2020)
  • Table 21. Asia Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ billion), By Country (2013 - 2020)
  • Table 22. Rest of the World (RoW), Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ billion),By Country (2013 - 2020)
  • Table 23. Global Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Inflammatory Conditions (2013 - 2020)
  • Table 24. Global Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ billion), By Regions (2013 - 2020)
  • Table 25. North America Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ billion), By Country (2013 - 2020)
  • Table 26. Europe Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ billion), By Country (2013 - 2020)
  • Table 27. Asia Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ billion), By Country (2013 - 2020)
  • Table 28. Rest of the World (RoW) Prescription Pharmaceuticals Market Size & Forecast for Inflammatory Conditions (US$ billion), By Country (2013 - 2020)
  • Table 29. Global Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Infectious Diseases (2013 - 2020)
  • Table 30. Global Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ billion),By Regions (2015 vs. 2020)
  • Table 31. Global Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ billion), By Regions (2013 - 2020)
  • Table 32. North America Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ billion), By Country (2013 - 2020)
  • Table 33. Europe Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ billion), By Country (2013 - 2020)
  • Table 34. Asia Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ billion), By Country (2013 - 2020)
  • Table 35. Rest of the World (RoW)Prescription Pharmaceuticals Market Size & Forecast for Infectious Diseases (US$ billion), By Country (2013 - 2020)
  • Table 36. Global Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Metabolic Disorders (2013 - 2020)
  • Table 37. Global Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ billion), By Regions (2013 - 2020)
  • Table 38. North America Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ billion), By Country (2013 - 2020)
  • Table 39. Europe Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ billion), By Country (2013 - 2020)
  • Table 40. Asia Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ billion), By Country (2013 - 2020)
  • Table 41. Rest of the World (RoW) Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ billion),By Country (2013 - 2020)
  • Table 42. Global Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Respiratory Disorders (2013 - 2020)
  • Table 43. Global Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ billion), By Regions (2013 - 2020)
  • Table 44. North America Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ billion), By Country (2013 - 2020)
  • Table 45. Europe Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ billion), By Country (2013 - 2020)
  • Table 46. Asia Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ billion), By Country (2013 - 2020)
  • Table 47. Rest of the World (RoW) Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ billion), By Country (2013 - 2020)
  • Table 48. Global Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Other Therapeutic Segments (2013 - 2020)
  • Table 49. Global Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ billion), By Regions (2013 - 2020)
  • Table 50. North America Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ billion), By Country (2013 - 2020)
  • Table 51. Europe Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ billion), By Country (2013 - 2020)
  • Table 52. Asia Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ billion), By Country (2013 - 2020)
  • Table 53. Rest of the World (RoW) Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ billion), By Country (2013 - 2020)
  • Table 54. Global Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Formulations (2013 - 2020)
  • Table 55. Global Capsules Market Size & Forecast (US$ billion) (2013 - 2020)
  • Table 56. Global Capsules Market Size & Forecast (US$ billion), By Regions (2013 - 2020)
  • Table 57. Global Tablets Market Size & Forecast (US$ billion), (2013 - 2020)
  • Table 58. Global Tablets Market Size & Forecast (US$ billion), By Regions (2013 - 2020)
  • Table 59. Global Inhalants and Liquids Market Size & Forecast (US$ billion), (2013 - 2020)
  • Table 60. Global Inhalants and Liquids Market Size & Forecast (US$ billion), By Regions (2013 - 2020)
  • Table 61. Global Parenteral Market Size & Forecast (US$ billion), (2013 - 2020)
  • Table 62. Global Parenterals Market Size & Forecast (US$ billion), By Regions (2013 - 2020)
  • Table 63. Global TopicalsMarket Size & Forecast (US$ billion), (2013 - 2020)
  • Table 64. Global Topicals Market Size & Forecast (US$ billion), By Regions (2013 - 2020)
  • Table 65. Global Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Regions (2013 - 2020)
  • Table 66. North America Prescription Pharmaceuticals Market Size & Forecast (US$ billion),By Country (2013 - 2020)
  • Table 67. North America Prescription Pharmaceuticals Market Size & Forecast (US$ billion), (2013 - 2020)
  • Table 68. North America Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Therapeutic Segments (2013 - 2020)
  • Table 69. North America Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Formulations (2013 - 2020)
  • Table 70. Europe Prescription Pharmaceuticals Market Size & Forecast (US$ billion),By Country (2013 - 2020)
  • Table 71. Europe Prescription Pharmaceuticals Market Size & Forecast (US$ billion), (2013 - 2020)
  • Table 72. Europe Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Therapeutic Segments (2013 - 2020)
  • Table 73. Europe Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Formulations (2013 - 2020)
  • Table 74. Asia Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Country (2013 - 2020)
  • Table 75. Asia Prescription Pharmaceuticals Market Size & Forecast (US$ billion), (2013 - 2020)
  • Table 76. Asia Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Therapeutic Segments (2013 - 2020)
  • Table 77. Asia Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Formulations (2013 - 2020)
  • Table 78. RoW Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Country, (2013 - 2020)
  • Table 79. RoW Prescription Pharmaceuticals Market Size & Forecast (US$ billion), (2013 - 2020)
  • Table 80. RoW Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Therapeutic Segments (2013 - 2020)
  • Table 81. RoW Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Formulations (2013 - 2020)
  • Table 82. Financial Overview: AstraZeneca plc (U.K.) (Europe) (2013 to 2015)
  • Table 83. Revenues of Top-3 Pharmaceutical Products AstraZeneca plc (U.K.) (Europe) (2013 to 2015)
  • Table 84. Financial Overview: Bayer AG (Germany)(Europe) (2013 to 2015)
  • Table 85. Revenues of Top-3 Pharmaceutical Products:Bayer AG (Germany)(Europe) (2013 to 2015)
  • Table 86. Financial Overview: Gilead Sciences, Inc. (U.S.)(2013 to 2015)
  • Table 87. Revenues of Top-3 Pharmaceutical Products:Gilead Sciences, Inc. (U.S.) (2013 to 2015)
  • Table 88. Financial Overview: GlaxoSmithKline plc (U.K.) (Europe)(2013 to 2015)
  • Table 89. Revenues of Top-3 Pharmaceutical Products:GlaxoSmithKline plc (U.K.) (Europe) (2013 to 2015)
  • Table 90. Financial Overview: Johnson & Johnson (U.S.) (2013 to 2015)
  • Table 91. Revenues of Top-3 Pharmaceutical Products: Johnson & Johnson (U.S.) (2013 to 2015)
  • Table 92. Financial Overview: Merck & Co., Inc. (U.S.) (2013 to 2015)
  • Table 93. Revenues of Top-3 Pharmaceutical Products: Merck & Co., Inc. (U.S.) (2013 to 2015)
  • Table 94. Financial Overview: Novartis AG (Switzerland) (Europe) (2013 to 2015)
  • Table 95. Revenues of Top-3 Pharmaceutical Products: Novartis AG (Switzerland) (Europe) (2013 to 2015)
  • Table 96. Financial Overview: Pfizer Inc. (U.S.) (2013 to 2015)
  • Table 97. Revenues of Top-3 Pharmaceutical Products: Pfizer Inc. (U.S.) (2013 to 2015)
  • Table 98. Financial Overview: F. Hoffmann-La Roche (Switzerland) (Europe) (2013 to 2015)
  • Table 99. Revenues of Top-3 Pharmaceutical Products: Hoffmann-La Roche (Switzerland) (Europe) (2013 to 2015)
  • Table 100. Financial Overview: Sanofi S.A. (France) (Europe) (2013 to 2015)
  • Table 101. Revenues of Top-3 Pharmaceutical Products: Sanofi S.A. (France) (Europe) (2013 to 2015)
  • Table 102. Acronyms

List of Figures

  • Figure 1. Research Methodology
  • Figure 2. Prescription Pharmaceuticals Market,By Therapeutic Segments
  • Figure 3. Prescription Pharmaceuticals Market, By Formulations
  • Figure 4. Prescription Pharmaceuticals Market, By Regions
  • Figure 5. Global Prescription Pharmaceuticals Market Size& Forecast (US$ billion),By Therapeutic Segments (2015)
  • Figure 6. Global Prescription Pharmaceuticals for Cardiovascular Disorders Market Size & Forecast (US$ billion), By Regions (2015 vs. 2020)
  • Figure 7. Global Prescription Pharmaceuticals for Oncology Market Size & Forecast (US$ billion), By Regions (2015 vs. 2020)
  • Figure 8. Global Prescription Pharmaceuticals Market Size& Forecast for Inflammatory Conditions (US$ billion), By Regions (2015 vs. 2020)
  • Figure 9. Global Prescription Pharmaceuticals Market Size & Forecast for Metabolic Disorders (US$ billion), By Regions (2015 vs. 2020)
  • Figure 10. Global Prescription Pharmaceuticals Market Size & Forecast for Respiratory Disorders (US$ billion), By Regions (2015 vs. 2020)
  • Figure 11. Global Prescription Pharmaceuticals Market Size & Forecast for Other Therapeutic Segments (US$ billion), By Regions (2015 vs. 2020)
  • Figure 12. Global Prescription Pharmaceuticals Market Size & Forecast (US$ billion), By Formulations (2015)
  • Figure 13. Global Capsules Market Size & Forecast (US$ billion), By Regions (2015 vs. 2020)
  • Figure 14. Global Tablets Market Size & Forecast (US$ billion), By Regions (2015 vs. 2020)
  • Figure 15. Global Inhalants and Liquids Market Size & Forecast (US$ billion), By Regions (2015 vs. 2020)
  • Figure 16. Global Parenteral Market Size & Forecast (US$ billion), By Regions (2015 vs. 2020)
  • Figure 17. Global Topicals Market Size & Forecast (US$ billion), By Regions (2015 vs. 2020)
  • Figure 18. Global Prescription Pharmaceuticals Market Size vs. CAGR% (2015 - 2020), By Regions
  • Figure 19. Market Share Analysis
  • Figure 20. Market Positioning of Key Players
Back to Top